<- Go Home
Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Market Cap
$3.9M
Volume
98.9K
Cash and Equivalents
$17.8M
EBITDA
-$13.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$3.04
52 Week Low
$0.56
Dividend
N/A
Price / Book Value
0.23
Price / Earnings
-0.31
Price / Tangible Book Value
0.23
Enterprise Value
-$13.9M
Enterprise Value / EBITDA
1.01
Operating Income
-$13.8M
Return on Equity
53.03%
Return on Assets
-33.21
Cash and Short Term Investments
$17.8M
Debt
N/A
Equity
$17.2M
Revenue
N/A
Unlevered FCF
-$10.5M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium